These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3689423)

  • 1. Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors.
    el Kouni MH; Messier NJ; Cha S
    Biochem Pharmacol; 1987 Nov; 36(22):3815-21. PubMed ID: 3689423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of adenosine analogues by Schistosoma mansoni and the effect of nucleoside transport inhibitors.
    el Kouni MH; Cha S
    Biochem Pharmacol; 1987 Apr; 36(7):1099-106. PubMed ID: 3566804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of schistosomiasis by tubercidin and nitrobenzylthioinosine 5'-monophosphate.
    el Kouni MH; Diop D; Cha S
    Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6667-70. PubMed ID: 6579551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of Schistosoma japonicum by tubercidin and nitrobenzylthioinosine 5'-monophosphate.
    el Kouni MH; Knopf PM; Cha SM
    Biochem Pharmacol; 1985 Nov; 34(21):3921-3. PubMed ID: 3933515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of combination therapy with tubercidin and nitrobenzylthioinosine 5'-monophosphate against chronic and advanced stages of schistosomiasis.
    el Kouni MH
    Biochem Pharmacol; 1991 Mar; 41(5):815-20. PubMed ID: 1900158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice against lethal dosages of nebularine by nitrobenzylthioinosine, an inhibitor of nucleoside transport.
    Paterson AR; Paran JH; Yang S; Lynch TP
    Cancer Res; 1979 Sep; 39(9):3607-11. PubMed ID: 476687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5'-monophosphate for the treatment of schistosomiasis.
    el Kouni MH; Diop D; O'Shea P; Carlisle R; Sommadossi JP
    Antimicrob Agents Chemother; 1989 Jun; 33(6):824-7. PubMed ID: 2764531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mouse neoplasms with high doses of tubercidin.
    Lynch TP; Jakobs ES; Paran JH; Paterson AR
    Cancer Res; 1981 Aug; 41(8):3200-4. PubMed ID: 7248975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
    Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
    Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial action of nitrobenzylthioinosine in combination with purine nucleoside antimetabolites.
    Gero AM; Scott HV; O'Sullivan WJ; Christopherson RI
    Mol Biochem Parasitol; 1989 Apr; 34(1):87-97. PubMed ID: 2651920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of mouse leukemia L1210 with combinations of nebularine and nitrobenzylthioinosine 5'-monophosphate.
    Lynch TP; Paran JH; Paterson AR
    Cancer Res; 1981 Feb; 41(2):560-5. PubMed ID: 7448803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx.
    Prus KL; Averett DR; Zimmerman TP
    Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of toxicity and tissue distribution of tubercidin in mice by nitrobenzylthioinosine 5'-monophosphate.
    Kolassa N; Jakobs ES; Buzzell GR; Paterson AR
    Biochem Pharmacol; 1982 May; 31(10):1863-74. PubMed ID: 7104018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the tubercidin antileishmania action associated with an inhibitor of the nucleoside transport.
    Aoki JI; Yamashiro-Kanashiro EH; Ramos DC; Cotrim PC
    Parasitol Res; 2009 Jan; 104(2):223-8. PubMed ID: 18787843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
    Dawicki DD; Agarwal KC; Parks RE
    Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effectiveness of several nucleoside transport inhibitors in mice and hamsters.
    Baer HP; Serignese V; Moorji A; Van Belle H
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):365-9. PubMed ID: 1852220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of nitrobenzylthioinosine and purine beta-L-nucleosides by intracellular Toxoplasma gondii.
    Al Safarjalani ON; Naguib FN; El Kouni MH
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3247-51. PubMed ID: 14506037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
    Endres CJ; Sengupta DJ; Unadkat JD
    Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of nucleoside transport sites into the host cell membrane of Babesia bovis infected erythrocytes.
    Gero AM
    Mol Biochem Parasitol; 1989 Jul; 35(3):269-76. PubMed ID: 2747745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.